Prevention of viral hepatitis in the Nordic countries and Germany

References

• Iwarson S. Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK). Vaccine 1998; 16((Suppl))S63–4
   Google Scholar
• Jensen L, Heilmann C, Smith E, Wantzin P, Peitersen B, Weber T, Krogsgaard K. Efficacy of selective antenatal screening for hepatitis B among pregnant women in Denmark: is selective screening still an acceptable strategy in a low-endemicity country?. Scand J Infect Dis 2003; 35: 378–82
   PubMed Web of Science ®Google Scholar
• Böttiger M, Christenson B, Grillner L. Hepatitis A immunity in the Swedish population. A study of the prevalence of markers in the Swedish population. Scand J Infect Dis 1997; 29: 99–102
   PubMed Web of Science ®Google Scholar
• Pebody RG, Ruutu P, Nohynek H, Leinikki P. Changing epidemiology of hepatitis B infection in Finland. Scand J Infect Dis 1999; 31: 251–4
   PubMedGoogle Scholar
• Christensen PB, Krarup HB, Niesters HG, Norder H, Schaffalitzky de Muckadell OB, Jeune B, Georgsen J. Outbreak of hepatitis B among injecting drug users in Denmark. J Clin Virol 2001; 22: 133–41
   PubMedGoogle Scholar
• European Monitoring Centre for drugs and drug addiction (EMCDDA). Annual report 2003: the state of the drugs problem in the European Union and Norway. Lisbon. 2003.
   Google Scholar
• Miller M, Mella I, Moi H, Eskild A. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway. J AIDS 2003; 33: 373–9
   PubMed Web of Science ®Google Scholar
• Bundesgesetzblatt. Infection Protection Act: Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen (Infektionsschutzgesetz–IfSG). 2000; 1045.
   Google Scholar
• Müller HE. Notification according to the law for protection against infections. Gesundheitswesen 2001; 63: 755–8
   PubMedGoogle Scholar
• Robert Koch-Institut. Falldefinitionen des Robert Koch-Instituts zur Übermittlung von Erkrankungs- oder Todesfällen und Nachweisen von Kranksheitserregern. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2004;47:165–206. http://www.rki.de/cln_011/nn_349724/DE/Content/Infekt/IfSG/Falldefinition/IfSG/Falldefinition,templateId = raw,property = publicationFile.pdf/Falldefinition, , [Accessed April 2005] .
   Google Scholar
• Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001; 17: 429–35
   PubMedGoogle Scholar
• Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2003. Mercedes-DruckBerlin. 2004. http://www.rki.de/cln_006/nn_226624/DE/Content/Infekt/Jahrbuch/Jahrbuch__2003,templateId = raw,property = publicationFile.pdf/Jahrbuch_2003, , [Accessed April 2005].
   Google Scholar
• Thefeld W. Hepatitis B Durchseuchung in der deutschen Bevölkerung. Bundesgesundhbl 1994; 37: 372–7
   Google Scholar
• Kramer A, Prufer-Kramer L. Experience with the new German hepatitis B vaccination strategy since 1995. Int J STD AIDS 2002; 13(Suppl 2)35–7
   PubMedGoogle Scholar
• Robert Koch-Institut. Mitteilungen der Ständigen Impfkommission am Robert Koch-Institut: Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2004. Epi Bull. 2004;30:235–50. http://www.rki.de/cln_011/nn_243990/DE/Content/Infekt/EpidBull/Archiv/2004/30__04,templateId = raw,property = publicationFile.pdf/30_04, , [Accessed April 2005].
   Google Scholar
• Dausch E, Jilg E. HBsAg-Screening in der Schwangerschaft – Durchführung und Effizienz. Eine Studie an 6083 Schwangeren in 11 bayerischen Kliniken. Geburtsh Frauenheilk 2001; 61: 676–81
   Google Scholar
• Mercer CH, Fenton KA, Copas AJ, Wellings K, Erens B, McManus S, et al. Increasing prevalence of male homosexual partnerships and practices in Britain 1990–2000: evidence from national probability surveys. AIDS 2004; 18: 1453–8
   PubMed Web of Science ®Google Scholar
• Weber B, Rabenau H, Berger A, Scheuermann EH, Staszewski S, Kreuz W, et al. Seroprevalence of HCV, HAV, HBV, HDV, HCMV and HIV in high risk groups. Frankfurt a.M., Germany. Zbl Bakt 1995; 282: 102–12
   PubMedGoogle Scholar
• Kleiber, D, Wilke, M. 1995. AIDS, Sex und Tourismus. Ergebnisse einer Befragung deutscher Urlauber und Sextouristen. Band 33, Schriftenreihe des Bundesministeriums für Gesundheit. Baden-Baden: Nomos Verlagsgesellschaft. ISBN: 3-7890-3707-9.
   Google Scholar
• Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997; 26: 1359–66
   PubMed Web of Science ®Google Scholar
• Chamot E, de Saussure P, Hirschel B, Deglon JJ, Perrin LH. Incidence of hepatitis C, hepatitis B and HIV infections among drug users in a methadone-maintenance programme. AIDS 1992; 6: 430–1
   PubMedGoogle Scholar
• Mansson AS, Moestrup T, Nordenfelt E, Widell A. Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 2000; 32: 253–8
   PubMed Web of Science ®Google Scholar
• Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: a review of international research and development. Addiction 2003; 98: 153–8
   PubMed Web of Science ®Google Scholar
• Ambrosch F, Wiedermann G, Kundi M, Leroux-Roels G, Desombere I, Garcon N, et al. A hepatitis B vaccine formulated with a novel adjuvant system. Vaccine 2000; 18: 2095–101
   PubMed Web of Science ®Google Scholar
• Bienzle U, Günther M, Neuhaus R, Vandepapeliere P, Vollmar J, Lun A, Neuhaus P. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003; 38: 811–9
   PubMed Web of Science ®Google Scholar
• Offergeld R, Faensen D, Ritter S, Hamouda O. Human immunodeficiency virus, hepatitis C, hepatitis B infections among blood donors in Germany 2000–2002, risk of virus transmission and the impact of nucleic acid amplification testing. Eurosurveillance 2005; 10: 2
   Google Scholar
• Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104–8
   PubMed Web of Science ®Google Scholar
• Grob P, Jilg W, Bornhak H, Gerken G, Gerlich WH, Günther S, et al. The serological pattern ‘anti HBc alone’. Report on a workshop. J Med Virol 2000; 62: 450–5
   PubMedGoogle Scholar
• Westhoff TH, Jochimsen F, Schmittel A, Stöffler-Meilicke M, Schäfer JH, Zidek W, et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 2003; 102: 1930
   PubMed Web of Science ®Google Scholar
• Polywka S, Feucht H, Zöllner B, Laufs R. Hepatitis C virus infection in pregnancy and the risk of mother-to-child transmission. Eur J Clin Microbiol Inf Dis 1997; 16: 121–4
   PubMedGoogle Scholar
• Backmund M, Meyer K, Wächtler M, Eichenlaub D. Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. Eur J Epidemiol 2003; 18: 563–8
   PubMed Web of Science ®Google Scholar
• Offergeld R, Stark K, Hamouda O. Infektionen bei Blutspendern. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2003; 46: 775–9
   Google Scholar
• Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol 2000; 60: 122–5
   PubMedGoogle Scholar
• Robotin MC, Copland J, Tallis G, Coleman D, Giele C, Carter L, et al. Surveillance for newly acquired hepatitis C in Australia. J Gastroent Hepatol 2004; 19: 283–8
   PubMed Web of Science ®Google Scholar
• Wiese M, Berr F, Lafrenz M, Porst H, Ösen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicentre study. Hepatology 2000; 32: 91–6
   PubMed Web of Science ®Google Scholar
• Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41–52
   PubMed Web of Science ®Google Scholar
• Ross S, Roggendorf M. Epidemiologie der hepatitis C-Infektion und das Problem nosokomialer Übertragungen durch infiziertes medizinisches Personal. Koinfektion Hepatitis und HIV, S Mauss, JK Rockstroh, H Jager. Thieme, Stuttgart 2002; 1–8
   Google Scholar
• Cockcroft A. Surgeons who test positive for hepatitis C should not be transferred to low risk duties. Rev Med Virol 2000; 10: 79–82
   PubMedGoogle Scholar
• Heptonstall J. Surgeons who test positive for hepatitis C should be transferred to low risk duties. Rev Med Virol 2000; 10: 75–8
   PubMedGoogle Scholar
• Ross RS, Viazov S, Roggendorf M. Risk of hepatitis C transmission from infected medical staff to patients: model-based calculations for surgical settings. Arch Intern Med 2000; 160: 2313–6
   PubMedGoogle Scholar
• Gunson RN, Shouval D, Roggendorf M, Zaaijer H, Nicholas H, Holzmann H, et al. on behalf of the European Consensus Group. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003; 27: 213–30
   PubMedGoogle Scholar
• Gerlich W. Hepatitis B und C: Übertragungsgefahr auf Patienten durch infiziertes medizinisches Personal. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2004; 47: 369–78
   PubMedGoogle Scholar
• DVV (Deutsche Vereinigung zur Bekämpfung von Viruskrankheiten). Empfehlungen zur Verhütung der Übertragung von hepatitis-C-Virus durch infiziertes Personal im Gesundheitsdienst. Epidemiologisches Bulletin, 2001;3:15–6. http://www.rki.de/cln_011/nn_244010/DE/Content/Infekt/EpidBull/Archiv/2001/03__01,templateId = raw,property = publicationFile.pdf/03_01, , [Accessed April 2005]
   Google Scholar
• DVV (Deutsche Vereinigung zur Bekämpfung von Viruskrankheiten). 2004. Empfehlungen zur Prävention der nosokomialen Übertragung von hepatitis B Virus (HBV) und hepatitis C Virus (HCV) durch im Gesundheitswesen Tätige (as of January 2004), In: RS Ross, Roggendorf, M, editors. Übertragungsrisiko von HBV, HCV und HIV durch infiziertes medizinisches Personal. Lengerich, Berlin, Riga, Rom, Wien, Zagreb: Pabst Science Publishers.
   Google Scholar
• SR Ross, Roggendorf, M, (editors). 2004. Übertragungsrisiko von HBV, HCV und HIV durch infiziertes medizinisches Personal. Lengerich, Berlin, Riga, Rom, Wien, Zagreb: Pabst Science Publishers.
   Google Scholar
• Bricout F, Moraillon A, Sonntag P, Hörner P, Blackwelder W, Plotkin S. Virus-inhibiting surgical glove to reduce the risk of infection by enveloped viruses. J Med Virol 2003; 69: 538–45
   PubMedGoogle Scholar